Recognising contributions to work in research collaboratives: Guidelines for standardising reporting of authorship in collaborative research

Blencowe, Natalie S; Glasbey, James; Heywood, Nick; Kasivisvanathan, Veeru; Lee, Matthew J.; Nepogodiev, Dmitri; Wilkin, Richard; Allen, Stuart M.; Borakati, Aditya; Bosanquet, David C.; Chapman, Stephen J.; Chari, Ajai; Dunstan, M; Dyson, Edward; Edlmann, Ellie; Gardner, Matthew D.; Harries, Rhiannon L; Hunter, James C.; Kolias, Angelos G.; Jamjoom, Aimun A B; McGrath, John A.; Mohan, Helen; Morrison, Rory; Nana, Gael R; Pinho-Gomes, Ana-Catarina; McCain, Scott; Reynolds, Rhianon; Sheikh, Shafaque; Shalhoub, Joseph; Stimpson, Amy; Boxel, Nicholas Symons Gijs van; West, Malcolm; Wild, Jonathan; Baker, D.; Barmayehvar, Behrad; Bath, Michael; Beamish, Andrew J.; Bhangu, Aneel; Canter, Richard; Clements, Joshua; Cotton, Arthur; Dabab, Nedal; Doherty, Daniel T.; Fitzgerald, J Edward; Heywood, Emily; Johnston, Maximilian J.; Hickland, P; Kamarajah, Sivesh K.; Hoo, Chris; Marshall, Jack; McClean, Kenneth; Morley, R; Srikandarajah, Nisaharan; Fleming, Simon; Stephens, Nathan; Ward, Alex; Yasin, I H; Yasin, Tariq; Morton, Dion; Blazeby, Jane M; Pinkney, Thomas; Rangan, Amar; Bach, Simon; Williams, Adam

doi:10.1016/j.ijsu.2017.12.019

Cited by 41 publications

(26 citation statements)

References 9 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Local arrangements may include daily review of the patient and notes focused on included data points, reviewing patient status in outpatient clinics or via telephone interview at 30 days (if this is normal practice) and checking for readmission through handover lists. All investigators will be listed as collaborators on resulting publications in accordance with previous consensus guidelines for collaborative group research 13…”

Section: Methods and Analysismentioning

confidence: 99%

Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3)

2019

BMJ Open

View full text Add to dashboard Cite

IntroductionEmpirical, observational data relating to the diagnosis, management and outcome of three common worldwide cancers requiring surgery is lacking. However, it has been demonstrated that patients in low/middle-income countries undergoing surgery for cancer are at increased risk of death and major complications postoperatively. This study aims to determine quality and outcomes in breast, gastric and colorectal cancer surgery across worldwide hospital settings.Methods and analysisThis multicentre, international prospective cohort study will be undertaken by any hospital providing emergency or elective surgical services for breast, gastric or colorectal cancer. Centres will collect observational data on consecutive patients undergoing primary emergency or elective surgery for breast, gastric or colorectal cancer during a 6-month period. The primary outcome is the incidence of mortality and major complication rate at 30 days after cancer surgery. Infrastructure and care processes in the treatment of these cancers worldwide will also be characterised.Ethics and disseminationThis project will not affect clinical practice and has been classified as clinical audit following research ethics review. The protocol will be disseminated through the international GlobalSurg network.Trial registration numberNCT03471494; Pre-results.

show abstract

Section: Methods and Analysismentioning

confidence: 99%

Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3)

2019

BMJ Open

View full text Add to dashboard Cite

show abstract

“…Research Collaborative [24]. There will be no named authors in the main authorship line but individuals will be named within the paper and roles will be defined.…”

Section: Results Dissemination and Authorship Policymentioning

confidence: 99%

“…The main results manuscript for the trial and any subsequent secondary analysis manuscripts using the data collected in the trial will be published under a corporate authorship policy. The authorship policy will closely mirror the suggestion published by the National Research Collaborative [24]. There will be no named authors in the main authorship line but individuals will be named within the paper and roles will be defined.…”

Section: Adverse Events and Serious Adverse Eventsmentioning

confidence: 99%

An international pragmatic randomized controlled trial to compare a single‐use negative‐pressure dressing versus the surgeon’s preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol

Wilkin¹,

Clouston²,

Coe³

et al. 2021

Colorectal Disease

Self Cite

View full text Add to dashboard Cite

Aim: Surgical site infection (SSI) is a common complication following emergency laparotomy, occurring in around 25% of patients in UK practice. The adoption of single-use negative-pressure dressings (SUNPDs) has been proposed as a prophylactic method of reducing the rate of SSI. The primary aim of the randomized controlled trial (RCT) described herein is to determine if a SUNPD reduces SSI at 30 days after an emergency laparotomy. Method:The Single Use Negative pRessure dressing for Reduction In Surgical site infection following Emergency laparotomy (SUNRRISE) study is an international, multicentre, pragmatic, phase III RCT with internal feasibility phase. As stated, the primary aim is to determine if a SUNPD reduces SSI at 30 days postoperatively. Patients will be randomized in a 1:1 ratio to receive either a SUNPD or a dressing of the surgeon's preference. Outcome assessors will be blinded to treatment allocation. The primary outcome measure is SSI within 30 days of surgery as defined by the US Centers for Disease Control criteria. A total of 840 patients will be required to detect a relative reduction of 40% in SSI rates (from 25% to 15%) with 90% power accounting for a 20% attrition rate. Discussion: SUNRRISE is an international, multicentre RCT evaluating the prophylactic use of SUNPD in primary closed emergency laparotomy wounds for the reduction of SSI.Our hypothesis is that a SUNPD is superior to the surgeon's preference of dressing in reducing SSIs at 30 days. The findings may influence dressing choice following emergency abdominal surgery in the future. Primary outcome(s)Surgical site infection at 30 days postprocedure Key secondary outcomes Length of hospital stay, wound complications, readmission rate, quality of life, cost effectiveness, patient acceptability

show abstract

“…We intend to publish and present our study outcomes in peer-reviewed medical journals and conferences, respectively. In publications including national data, as per the BNTRC 17 and Association of Surgeons in Training (ASiT) 21 models, all participating researchers will be named as PubMed-citable collaborators. The REDCap database allows visibility of data input and will ensure that named collaborators have contributed towards the study.…”

Section: Dissemination Planmentioning

confidence: 99%

UK Chiari 1 Study: protocol for a prospective, observational, multicentre study

et al. 2021

View full text Add to dashboard Cite

IntroductionChiari 1 malformation (CM1) is a structural abnormality of the hindbrain characterised by the descent of the cerebellar tonsils through the foramen magnum. The management of patients with CM1 remains contentious since there are currently no UK or international guidelines for clinicians. We therefore propose a collaborative, prospective, multicentre study on the investigation, management and outcome of CM1 in the UK: the UK Chiari 1 Study (UKC1S). Our primary objective is to determine the health-related quality of life (HRQoL) in patients with a new diagnosis of CM1 managed either conservatively or surgically at 12 months of follow-up. We also aim to: (A) determine HRQoL 12 months following surgery; (B) measure complications 12 months following surgery; (C) determine the natural history of patients with CM1 treated conservatively without surgery; (D) determine the radiological correlates of presenting symptoms, signs and outcomes; and (E) determine the scope and variation within UK practice in referral patterns, patient pathways, investigations and surgical decisions.Methods and analysisThe UKC1S will be a prospective, multicentre and observational study that will follow the British Neurosurgical Trainee Research Collaborative model of collaborative research. Patients will be recruited after attending their first neurosurgical outpatient clinic appointment. Follow-up data will be collected from all patients at 12 months from baseline regardless of whether they are treated surgically or not. A further 12-month postoperative follow-up timepoint will be added for patients treated with decompressive surgery. The study is expected to last three years.Ethics and disseminationThe UKC1S received a favourable ethical opinion from the East Midlands Leicester South Research Ethics Committee (REC reference: 20/EM/0053; IRAS 269739) and the Health Research Authority. The results of the study will be published in peer-reviewed medical journals, presented at scientific conferences, shared with collaborating sites and shared with participant patients if they so wish.

show abstract

Recognising contributions to work in research collaboratives: Guidelines for standardising reporting of authorship in collaborative research

Cited by 41 publications

References 9 publications

Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3)

Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3)

An international pragmatic randomized controlled trial to compare a single‐use negative‐pressure dressing versus the surgeon’s preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol

UK Chiari 1 Study: protocol for a prospective, observational, multicentre study

Contact Info

Product

Resources

About